One68 Global Capital’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$49.1K Sell
21,514
-20,000
-48% -$63.4K 0.16% 39
2025
Q4
$166K Buy
+41,514
New +$231K 1.96% 27
2025
Q2
Sell
-525,238
Closed -$4.97M 15
2025
Q1
$4.97M Buy
525,238
+164,248
+45% +$1.66M 2.44% 10
2024
Q4
$4.06M Buy
+360,990
New +$6.34M 2.16% 8

Other funds holding EVH

One68 Global Capital's EVH Position: Q1 2026 in Review

One68 Global Capital reduced its Evolent Health (EVH) stake by 48% in Q1 2026, selling an estimated $63.4K and leaving 21,514 shares worth $49.1K. The position accounts for 0.16% of the portfolio, ranked #39.

One68 Global Capital first reported a position in EVH in Q4 2024 and has held it in 4 quarters since. The position peaked at $4.97M in Q1 2025. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • One68 Global Capital held 21,514 shares of Evolent Health worth $49.1K as of Q1 2026.
  • One68 Global Capital sold 20,000 Evolent Health shares in Q1 2026, an estimated $63.4K.
  • Evolent Health made up 0.16% of One68 Global Capital's portfolio in Q1 2026, its #39 holding.
  • One68 Global Capital first reported a position in Evolent Health in Q4 2024 and has held it in 4 quarters since.
  • One68 Global Capital's Evolent Health position peaked at $4.97M in Q1 2025.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on One68 Global Capital's 13F filing for Q1 2026, filed 15 May 2026.